title: The treatment journey of a patient with multidrug-resistant tuberculosis in South Africa: is it patient-centred?
abstract: To improve the treatment of patients co-infected with multidrug-resistant tuberculosis (MDR-TB) and the human immunodeficiency virus, we measured the relationship between treatment outcomes and hospital performance at four decentralised MDR-TB sites in South Africa. We describe hospital performance from the patient's perspective by the use of a graphic that visually represents a patient's treatment journey. The graphic was used to report study findings to study sites and as a catalyst for a quality improvement process.
authors.affiliation: Health Systems Research Unit, Medical Research Council, Cape Town, South Africa; Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa.
authors.forename: M
authors.initials: M
authors.lastname: Loveday
authors.affiliation: Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
authors.forename: N
authors.initials: N
authors.lastname: Padayatchi
authors.affiliation: Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa.
authors.forename: A
authors.initials: A
authors.lastname: Voce
authors.affiliation: Department of Medicine, Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, New York, USA.
authors.forename: J
authors.initials: J
authors.lastname: Brust
authors.affiliation: KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa.
authors.forename: K
authors.initials: K
authors.lastname: Wallengren
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003695:Delivery of Health Care / Q000458:organization & administration* / Q000592:standards; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000628:therapy*; D006801:Humans; D018802:Patient-Centered Care / Q000458:organization & administration; D011787:Quality of Health Care; D013019:South Africa / Q000453:epidemiology; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000628:therapy*
chemical_list: D000995:Antitubercular Agents
references.citation: Int J Tuberc Lung Dis. 2012 Aug;16(8):998-1004
references.pmid: 22668560
references.citation: Emerg Infect Dis. 2011 Oct;17(10):1913-6
references.pmid: 22000370
references.citation: Int J Tuberc Lung Dis. 2012 Feb;16(2):209-15
references.pmid: 22236922
references.citation: Health Policy Plan. 2008 Jan;23(1):56-66
references.pmid: 17942447
references.citation: Int J Tuberc Lung Dis. 2009 May;13(5):548-50
references.pmid: 19383184
references.citation: Health Policy. 2008 Feb;85(2):162-71
references.pmid: 17767974
references.citation: Bull World Health Organ. 2002;80(6):489-95; discussion 495-500
references.pmid: 12132008
references.citation: BMC Infect Dis. 2008 Jan 25;8:10
references.pmid: 18221534
references.citation: Int J Tuberc Lung Dis. 2005 Jun;9(6):640-5
references.pmid: 15971391
references.citation: AIDS. 2005 Oct;19 Suppl 3:S227-37
references.pmid: 16251823
references.citation: Health Policy Plan. 2012 Oct;27 Suppl 4:iv4-8
references.pmid: 23014152